Atherosclerosis
Volume 190, Issue 2 , Pages 378-384 , February 2007

Vasodilation in resistance arteries is related to the apolipoprotein B/A1 ratio in the elderly – The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study

Received 16 September 2005 ,Revised 30 January 2006 ,Accepted 2 February 2006.

References 

  1. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986;256:2823–2828
  2. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA. 1987;257:2176–2180
  3. Walldius G, Jungner I, Holme I, et al. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001;358:2026–2033
  4. Talmud PJ, Hawe E, Miller GJ, et al. Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Arterioscler Thromb Vasc Biol. 2002;22:1918–1923
  5. Yusuf S, Hawken S, Ounpuu S, et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(September):937–952
  6. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391–401
  7. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899–1906
  8. Perticone F, Ceravalo R, Puija A, et al. Prognostic significance of endothelial dysfuntion in hyptertensive patients. Circulation. 2001;104:191–196
  9. Chowienczyk PJ, Watts GF, Cockroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet. 1992;340:1430–1432
  10. Creager MA, Cooke JP, Medelsohn ME, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228–234
  11. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Karas RH. Comparison of flow-mediated dilatation of the brachial artery in coronary patients with low-density lipoprotein cholesterol levels <80mg/dl versus patients with levels 80–100mg/dl. Am J Cardiol. 2005;95:93–95
  12. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491–497
  13. Leung WH, Lau CP, Wong CK. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet. 1993;341:1496–1500
  14. Casino PR, Kilcoyne CM, Cannon RO, Quyyumi AA, Panza JA. Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolemia extends beyond the muscarinic receptor. Am J Cardiol. 1995;75:40–44
  15. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:1468–1474
  16. Sorensen KE, Celermajer DS, Georgakopoulos D, et al. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest. 1994;93:50–55
  17. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation. 1993;88:2541–2547
  18. Seiler C, Hess OM, Buechi M, Suter TM, Krayenbuehl HP. Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation. 1993;88:2139–2148
  19. Shiode N, Kato M, Hiraoka A, et al. Impaired endothelium-dependent vasodilation of coronary resistance vessels in hypercholesterolemic patients. Intern Med. 1996;35:89–93
  20. Vogel RA, Corretti MC, Plotnick GD. Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men. Am J Cardiol. 1996;77:37–40
  21. Stroes ES, Koomans HA, de Bruin TW, Rabelink TJ. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet. 1995;346:467–471
  22. Arcaro G, Zenere BM, Travia D, et al. Non-invasive detection of early endothelial dysfunction in hypercholesterolaemic subjects. Atherosclerosis. 1995;114:247–254
  23. Steinberg HO, Bayazeed B, Hook G, et al. Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation. 1997;96:3287–3293
  24. Steer P, Hulthe J, Millgård J, et al. Endothelial vasodilatory function is predicted by circulating apolipoprotein B and HDL in healthy humans. Lipids. 2002;37:1135–1140
  25. Lind L, Fors N, Hall J, Marttala K, Stenborg A. A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly. The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study. Arterioscler Thromb Vasc Biol. 2005;25:2368–2375
  26. Lind L, Sarabi M, Millgård J. Methodological aspects of the evaluation of endotelium-dependent vasodilatation in the human forearm. Clin Physiol. 1998;18:81–87
  27. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidlines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report from the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257–265
  28. Lind L, Hall J, Larsson A, et al. Evaluation of endothelium-dependent vasodilation in the human peripheral circulation. Clin Physiol. 2000;20:440–448
  29. Wilkinson IB, Hall IR, MacCallum H, et al. Pulse wave analysis. Clinical evaluation of a non-invasive, widely applicable method for assessing endothelial function. Arterioscler Thomb Vasc Biol. 2002;22:147–152
  30. Hayward CS, Kraidly M, Webb CN, Collins P. Assessment of endothelial function using peripheral waveform analysis. A clinical application. J Am Coll Cardiol. 2002;40:521–528
  31. Lind L, Pettersson K, Johansson K. Analysis of endothelium-dependent vasodilation by use of the radial artery pulse wave obtained by applanation tonometry. Clin Physiol Funct Imaging. 2003;23:50–57
  32. Simons LA, Simons J, Friedlander Y, McCallum J. Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years. Atherosclerosis. 2001;159:201–208
  33. Wendelhag I, Fagerberg B, Hulthe J, Bokemark L, Wikstrand J. Endothelium-dependent flow-mediated vasodilation, insulin resistance and the metabolic syndrome in 60-year-old men. J Intern Med. 2002;252:305–313
  34. Witte DR, van der Graaf Y, Grobbee DE, Bots ML SMART Study Group. Measurement of flow-mediated dilatation of the brachial artery is affected by local elastic vessel wall properties in high-risk patients. Atherosclerosis. 2005;182:323–330
  35. Lind L, Hall J, Johansson K. Evaluation of four different methods to measure endothelium-dependent vasodilation in the human peripheral circulation. Clin Sci. 2002;102:561–567
  36. Preik M, Kelm M, Feelisch , Strauer BE. Imapired effectiviness of nitric oxide-donors in resistance areties of patients with arteraial hypertension. J Hypertens. 1996;14:903–908
  37. Andersson R, Dart AM, Starr J, Shaw J, Chin-Dusting JPF. Plasma C-reactive protein, but not protein S, VCAM-1, von Willebrand factor or P-selectin, is associated with endothelium dysfunction in coronary artery disease. Atherosclerosis. 2004;172:345–351
  38. Wierzbicki AS, Chowienczyk PJ, Cockcroft JR, et al. Cardiovascular risk factors and endothelial dysfunction. Clin Sci (Lond). 2004;107:609–615
  39. Sarabi M, Vessby B, Millgard J, Lind L. Endothelium-dependent vasodilation is related to the fatty acid composition of serum lipids in healthy subjects. Atherosclerosis. 2001;156:349–355

PII: S0021-9150(06)00065-7

doi: 10.1016/j.atherosclerosis.2006.02.027

Atherosclerosis
Volume 190, Issue 2 , Pages 378-384 , February 2007

Article Tools

* Image Usage & Resolution